Document Detail


Depressions following reserpine: a reevaluation.
MedLine Citation:
PMID:  4154501     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
F K Goodwin; W E Bunney
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in psychiatry     Volume:  3     ISSN:  0037-1971     ISO Abbreviation:  Semin Psychiatry     Publication Date:  1971 Nov 
Date Detail:
Created Date:  1975-02-18     Completed Date:  1975-02-18     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0235734     Medline TA:  Semin Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  435-48     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Depression / chemically induced*,  complications,  drug therapy,  therapy
Dreams / drug effects
Drug Therapy, Combination
Electroconvulsive Therapy
Humans
Hypertension / drug therapy
Imipramine / analogs & derivatives,  therapeutic use
Monoamine Oxidase Inhibitors / therapeutic use
Neurotransmitter Agents / metabolism
Reserpine / administration & dosage,  adverse effects*,  pharmacology,  therapeutic use
Risk
Sleep / drug effects
Time Factors
Chemical
Reg. No./Substance:
0/Monoamine Oxidase Inhibitors; 0/Neurotransmitter Agents; 50-49-7/Imipramine; 50-55-5/Reserpine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affi...
Next Document:  Basic concepts of psychopharmacological research as applied to the psychopharmacological analysis of...